Riskpilot← Back to searchSign inGet full accessHT Terveys Oy
OYDissolvedY-tunnus 3087095-5Mäntytie 7-A12Medical specialists activities · NACE 8622Est. 2019— employees
Revenue 2025
EUR 230K
-7% vs 2024
EBITDA margin
46.4%
-69% vs 2024
Equity ratio
89.6%
Financial strength
Net profit 2025
EUR 137K
+17% vs 2024
| Revenue | EUR 230K | -7% |
| EBITDA | EUR 107K | -69% |
| Net profit | EUR 137K | +17% |
| Total assets | EUR 653K | +13% |
| Equity | EUR 585K | +19% |
| Employees | — | — |
Legal name
HT Terveys Oy
Y-tunnus number
3087095-5
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
16. syyskuuta 2019
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-11-30
Financial year
January – December
Company purpose
Erikoislääkäripalvelujen tuottaminen potilaille, koulutus- ja konsultointipalvelujen tuottaminen, liikkeenjohdon konsultointi, luennointi sekä kustannustoiminta. Yhtiö voi harjoittaa lääketieteellistä tutkimustyötä. Yhtiö voi omistaa, hallita, vuokrata ja saneerata sekä välittää kiinteistöjä, liike- ja asuinhuoneistoja sekä kulkuneuvoja. Yhtiö voi harjoittaa arvopaperikauppaa.
Address
Mäntytie 7-A12
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 176 | 188 | 205 | 247 | 230 |
| Staff expenses | −2 | −5 | −14 | 17 | −73 |
| EBITDA | 143 | 151 | 158 | 342 | 107 |
| Depreciation & amort. | −3 | −9 | −7 | 6 | −6 |
| EBIT | 139 | 142 | 151 | 166 | 101 |
| Net financials | 3 | −16 | 1 | 10 | 63 |
| Profit before tax | 142 | 126 | 152 | 153 | 170 |
| Tax | 29 | 29 | 31 | 35 | −33 |
| Net profit | 114 | 97 | 120 | 118 | 137 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 371 | 418 | 501 | 580 | 653 |
| Equity | 228 | 307 | 407 | 490 | 585 |
| Long-term debt | 109 | 91 | 71 | 53 | 35 |
| Short-term debt | 33 | 21 | 23 | 37 | 33 |
| Total debt | 142 | 112 | 94 | 90 | 68 |
EBITDA margin
46.4%
This company
15.8%
Market median
+194% vs market
20212025
Equity ratio
89.6%
This company
38.2%
Market median
+135% vs market
20212025
Return on equity
23.5%
This company
18.4%
Market median
+28% vs market
20212025
Net profit margin
59.6%
This company
8.1%
Market median
+636% vs market
20212025
Asset turnover
0.35×
This company
1.12×
Market median
-69% vs market
20212025
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-12-01 – 2025-11-30
- Annual report 2024Filed via PRH / YTJ · Period 2023-12-01 – 2024-11-30
- Annual report 2023Filed via PRH / YTJ · Period 2022-12-01 – 2023-11-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-12-01 – 2022-11-30
- Annual report 2021Filed via PRH / YTJ · Period 2020-12-01 – 2021-11-30
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
HE Chief Executive Officer | Chief Executive Officer | 2019 |
JA | Audit | 2025 |
KK Deputy auditor | Deputy auditor | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2019 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HT Terveys Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hanna Erika Paatela | Chief Executive Officer | 0 companies |
| Jose Adam Juhani Kautonen | Audit | 0 companies |
| Kiri Kasperi Sopanen | Deputy auditor | 0 companies |
| Teemu Juhana Paatela | Board of Directors | 0 companies |